Hyppää sisältöön
    • FI
    • ENG
  • FI
  • /
  • EN
OuluREPO – Oulun yliopiston julkaisuarkisto / University of Oulu repository
Näytä viite 
  •   OuluREPO etusivu
  • Oulun yliopisto
  • Avoin saatavuus
  • Näytä viite
  •   OuluREPO etusivu
  • Oulun yliopisto
  • Avoin saatavuus
  • Näytä viite
JavaScript is disabled for your browser. Some features of this site may not work without it.

MiR-455-3p, miR-150 and miR-375 are aberrantly expressed in salivary gland adenoid cystic carcinoma and polymorphous adenocarcinoma

Brown, Amy L.; Al‐Samadi, Ahmed; Sperandio, Marcelo; Soares, Andresa Borges; Teixeira, Lucas Novaes; Martinez, Elizabeth F.; Dias Demasi, Ana Paula; Araújo, Vera Cavalcanti; Leivo, Ilmo; Salo, Tuula; Passador‐Santos, Fabricio (2019-06-05)

 
Avaa tiedosto
nbnfi-fe2019111943039.pdf (602.6Kt)
nbnfi-fe2019111943039_meta.xml (51.81Kt)
nbnfi-fe2019111943039_solr.xml (47.69Kt)
Lataukset: 

URL:
https://doi.org/10.1111/jop.12894

Brown, Amy L.
Al‐Samadi, Ahmed
Sperandio, Marcelo
Soares, Andresa Borges
Teixeira, Lucas Novaes
Martinez, Elizabeth F.
Dias Demasi, Ana Paula
Araújo, Vera Cavalcanti
Leivo, Ilmo
Salo, Tuula
Passador‐Santos, Fabricio
John Wiley & Sons
05.06.2019

Brown, AL, Al‐Samadi, A, Sperandio, M, et al. MiR‐455‐3p, miR‐150 and miR‐375 are aberrantly expressed in salivary gland adenoid cystic carcinoma and polymorphous adenocarcinoma. J Oral Pathol Med. 2019; 48: 840– 845. https://doi.org/10.1111/jop.12894

https://rightsstatements.org/vocab/InC/1.0/
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. This is the peer reviewed version of the following article: Brown, AL, Al‐Samadi, A, Sperandio, M, et al. MiR‐455‐3p, miR‐150 and miR‐375 are aberrantly expressed in salivary gland adenoid cystic carcinoma and polymorphous adenocarcinoma. J Oral Pathol Med. 2019; 48: 840– 845. https://doi.org/10.1111/jop.12894, which has been published in final form at https://doi.org/10.1111/jop.12894. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
https://rightsstatements.org/vocab/InC/1.0/
doi:https://doi.org/10.1111/jop.12894
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi-fe2019111943039
Tiivistelmä

Abstract

Background: Adenoid cystic carcinoma (AdCC) and polymorphous adenocarcinoma (PAC) are included among the most common salivary gland cancers. They share clinical and histological characteristics, making their diagnosis challenging in specific cases. MicroRNAs (miRNA) are short, non‐coding RNA sequences of 19–25 nucleotides in length that are involved in post‐transcriptional protein expression. They have been shown to play important roles in neoplastic and non‐neoplastic processes and have been suggested as diagnostic and prognostic markers.

Methods: This study, using quantitative RT–PCR, investigated miR–150, miR–455–3p and miR–375 expression, in order to identify a possible molecular distinction between AdCC and PAC.

Results: miRNA–150 and miRNA–375 expression was significantly decreased in AdCC and PAC compared with salivary gland tissue controls, whilst miRNA–455–3p showed significantly increased expression in AdCC when compared to PAC, (P < 0.05). miR–150, miR–357 and miR–455–3p expression in AdCC, PAC and control was not associated with age, gender nor with anatomic site (major and minor salivary glands) (P > 0.05).

Conclusion: MiR–455–3p could be used as a complimentary tool in the diagnosis of challenging AdCC cases.

Kokoelmat
  • Avoin saatavuus [37688]
oulurepo@oulu.fiOulun yliopiston kirjastoOuluCRISLaturiMuuntaja
SaavutettavuusselosteTietosuojailmoitusYlläpidon kirjautuminen
 

Selaa kokoelmaa

NimekkeetTekijätJulkaisuajatAsiasanatUusimmatSivukartta

Omat tiedot

Kirjaudu sisäänRekisteröidy
oulurepo@oulu.fiOulun yliopiston kirjastoOuluCRISLaturiMuuntaja
SaavutettavuusselosteTietosuojailmoitusYlläpidon kirjautuminen